BMRN icon

BioMarin Pharmaceuticals

498 hedge funds and large institutions have $15B invested in BioMarin Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 183 increasing their positions, 164 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
498
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$139M
Puts
$101M
Net Calls
Net Calls Change

Top Buyers

1 +$182M
2 +$130M
3 +$125M
4
Jennison Associates
Jennison Associates
New York
+$99.2M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$93M

Top Sellers

1 -$150M
2 -$135M
3 -$59.3M
4
PAI
Palo Alto Investors
California
-$40.3M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$38.6M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.86B
2
$1.5B
3
$1.43B
4
$1.23B
5
$694M
6
$641M
7
$534M
8
$468M
9
$333M
10
$253M
11
$221M
12
$200M
13
$182M
14
$177M
15
$176M
16
$163M
17
$154M
18
$147M
19
$142M
20
$131M
21
$130M
22
$125M
23
$123M
24
$119M
25
$110M